AI-powered care coordination platform for time-sensitive medical conditions
Viz.ai operates a clinical AI platform that detects time-sensitive conditions — large-vessel-occlusion stroke, pulmonary embolism, aortic aneurysm — on CT and MRI scans and instantly mobilizes specialist care teams. The company was valued at $1.2 billion in its 2022 Series D and has expanded across more than 1,500 U.S. hospitals. Sacra estimates roughly $40M in 2023 revenue with around 74% year-over-year growth, positioning Viz.ai as a frequently cited 2026 IPO candidate in healthcare AI.
Healthcare📍 San Francisco, CAFounded 2016
Current Valuation
$1.2B
as of 2022-Q2
UNICORN
QL Price
$1.2B
0% vs last round
QuantLogix's current estimate for Viz.ai, published 2026-10-07 — in line with the last disclosed round of $1.2B (2022-Q2).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$1.2B
2022-Q2
weight 0.05
How this price has held up
No round has priced for Viz.ai since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-10-07 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Viz.ai, 2026-10-07 (e92e51c862ada321).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookrumored
Is Viz.ai going public in 2026?
An IPO is rumored for 2026, with nothing filed. Viz.ai remains private and the date is not the company's.
What is Viz.ai's valuation in 2026?
Viz.ai is valued at $1.2B as of 2022-Q2, set by its Series D ($100M, Apr 2022). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Viz.ai filed an S-1?
No public S-1 is on file for Viz.ai as of 10/07/2026; the IPO is rumored.
Viz.ai has raised $250M in total, most recently a Series D of $100M in Apr 2022.
Is Viz.ai publicly traded — can you buy Viz.ai stock?
No. Viz.ai is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Viz.ai on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
CEO
Chris Mansi
Founded
2016
HQ
San Francisco, CA
Employees
~400
Total Raised
$250M
Est. Revenue
$40M (2023)
Growth
~74% YoY
Last Round
Series D — $100M (Apr 2022) · Lead: Tiger Global
IPO Status
rumored
Fundraising Status
Series D · $100M · 4y 6mo ago
rumoredTotal raised $250M
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series D
$100M
Apr 2022
Tiger Global
—
Vertical Intelligence — AI / ML
No verified Hugging Face organization found for Viz.ai — no attributable open-model footprint. Closed-weights labs are common; this is a distribution signal, not a capability judgment.
Checked huggingface.co as of 2026-10-04. Re-checked weekly.
Talent Signal
Hiring trend
▶ Hiring steady
0% vs 2026-08
Open roles
14
via ashby
Product-build share
36%
engineering, research, product, design
Trajectory
strengthening
balanced build + GTM — 36% builders vs 64% go-to-market/G&A — scaling both sides.
Recent senior hire: 1 senior hire (CRO).
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Key Executive Moves
INJallel HarratiCRO · 2026-08-16
From trusted-source news extraction (deep-enrich pipeline); dates approximate publication, not effective date.
Senior Platform Engineer Senior Software Engineer- Edge ServicesSenior Algorithm DeveloperSenior DevOps EngineerSenior Information Security ManagerBusiness Development Senior Director
Counted from Viz.ai's live job board as of 2026-09-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Founders & Key People
Chris MansiDavid Golan
Investors
Tiger Global · Insight Partners · Kleiner Perkins · Greenoaks Capital · Threshold Ventures · GV
Products
Viz Stroke (LVO detection)
Viz Cardio (pulmonary embolism, aneurysm)
Viz Subdural and ICH
Viz Connect (care coordination)
Viz HCM, RV/LV
Competitors
Aidoc · RapidAI · Rad AI · Caption Health
Healthcare AIMedical ImagingStroke Care
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q2. Refreshed quarterly.